Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05037032 · ClinicalTrials.gov registry record · Phase 4
Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude
A Phase 4 study, sponsored by VA Loma Linda Health Care System.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT05037032 is a Phase 4 study that has completed, run by VA Loma Linda Health Care System. The registered enrollment target is 16 participants.
The verdict
NCT05037032, a Phase 4 study, has completed, sponsored by VA Loma Linda Health Care System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
Sleep at altitude is often poor. The purpose of this study is to evaluate the effects of a single dose of the opioid antagonist, naltrexone, on sleep quality and periodic breathing after rapid ascent to \~3800m altitude.
Interventions
- DRUG Placebo
- DRUG Naltrexone Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-08-08 |
| Est. Completion | 2021-10-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05037032
The ClinicalTrials.gov registry entry for NCT05037032 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Loma Linda Health Care System, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05037032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05037032 about?
NCT05037032 is a clinical study titled "Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude". Sleep at altitude is often poor. The purpose of this study is to evaluate the effects of a single dose of the opioid antagonist, naltrexone, on sleep quality and periodic breathing after rapid ascent to \~3800m altitude.
What is the current status of trial NCT05037032?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2021-08-08. Estimated completion is 2021-10-17.
What interventions are being tested in trial NCT05037032?
The interventions under investigation include: Placebo (DRUG), Naltrexone Pill (DRUG).
Who is sponsoring clinical trial NCT05037032?
This trial is sponsored by VA Loma Linda Health Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.